human t lymphoid progenitor
Cell therapyexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Apr 30, 2019 (NCT03879876)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- LymphocytesSupplementation
supplementation - lymphocytes
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04707300 | Phase 1/Phase 2 (Phase 2) | Oct 31, 2021 | APHP - Hôpital Necker, Assistance Publique - Hôpitaux de Paris |
| NCT03879876 | Phase 1/Phase 2 (Phase 2) | Apr 30, 2019 | Assistance Publique - Hôpitaux de Paris, Institut National de la Santé Et de la Recherche Médicale, France, Paris Descartes University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Assistance Publique - Hôpitaux de Paris | Academic/Hospital | 2 | 2 | 1 | 2019 |
| APHP - Hôpital Necker | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Institut National de la Santé Et de la Recherche Médicale, France | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Paris Descartes University | Academic/Hospital | 1 | 0 | 1 | 2019 |
4 organizations
Page 1 / 1